Information  X 
Enter a valid email address

Feedback PLC (FDBK)

  Print          Annual reports

Friday 04 December, 2020

Feedback PLC

Bleepa to join DIT's first virtual event to India

RNS Number : 5239H
Feedback PLC
04 December 2020



Feedback plc


Bleepa selected for Department for International Trade India Healthcare Virtual Mission


· The India Healthcare Virtual Mission - 8-10 December

· India's healthcare market projected to grow to $372 billion by 2022

· Event enables engagement with key stakeholders and influencers in India's Healthcare industry


London, 4 December 2020: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, today announces that Bleepa has been selected by Healthcare UK, part of the Department for International Trade ("DIT"), to join a virtual healthcare mission to India, 8-10 December 2020.


DIT - India Healthcare Virtual Mission


This is the DIT's first virtual event to India, building on the success of trade delegations visiting India over the last four years. Leading British healthcare innovators in artificial intelligence in healthcare, digital health, smart diagnostics and home-care technology, for both the Covid and post-Covid world, are selected to join this mission, led by the Chairman of NHS England, Lord David Prior.

Innovation in healthcare delivery is a key priority for healthcare providers in India, as India's healthcare market is projected to grow to USD 372bn by 20221. The event offers the chance to interact with key stakeholders and influencers from the Indian healthcare industry, including high-profile speakers from reputed organisations on key issues/opportunities in the industry from both UK and India. Companies joining the mission will receive dedicated support from the DIT network.


Dr Tom Oakley, CEO of Feedback, commented:


"There are a number of potential opportunities for Bleepa within the large and growing Indian healthcare market such as with the newly announced National Digital Health Mission, which targets giving every Indian citizen a unique health ID and digitized health records.


"Bleepa has the ability to support the hub and spoke hospital system in India. With a population of 1.38 billion people, access to centres of excellence in the four major cities is not possible for all, with both capacity and funding limiting access to top tier treatment. We believe that Bleepa can provide the vital digital link between these centres of excellence and regional or even mobile care units, enabling millions more patients to receive the high standards of care targeted in the National Digital Health Mission.


"We believe that Bleepa's digital modular capabilities as a CE marked communications platform would make Bleepa an attractive option for the Indian market. We look forward to scoping the opportunities available with the support of Healthcare UK and DIT."








Feedback plc

Tom Oakley, CEO

Lindsay Melvin, CFO

+44 (0)1954 718072

[email protected]

Allenby Capital Limited (Nominated Adviser)

David Worlidge / Asha Chotai

+44 (0)20 3328 5656

Walbrook PR Ltd

Tel: 020 7933 8780 or [email protected]

Paul McManus/Nick Rome/Nicholas Johnson

07980 541 893 or 07748 325 236 or 07884 664 686

Notes to Editors


Feedback plc (AIM: FDBK) is a medical imaging technology business. Its core product, Bleepa, is a revolutionary medical imaging communications app, providing an easy-to-use, high quality tool to enable remote and secure communications between front-line clinicians and teams. Importantly, it is the only CE marked medical imaging communications platform on the NHSx clinical communications tools framework. Bleepa has unparalleled functionality for everyday practice and can be accessed from any internet-connected device, enabling control of patient cases when on the go.


Its highly scalable Software as a Service ("SaaS") based revenue model will provide increasing levels of visibility as the Company grows its customer base. With a growing distribution base and technology in place, the focus is on leveraging key relationships in order to drive sales both in the UK and internationally to all forms of care facilitators. As a fully certified medical device, Bleepa aims to disrupt the medical imaging communications market and, importantly, increase the accuracy and speed of diagnosis.


About Department for International Trade


The Department for International Trade (DIT) helps businesses export and grow into global markets. We also help overseas companies locate and grow in the UK.   Our services are provided in over 100 markets throughout the world. We are passionate about what we do. That's why we constantly review our services in light of customer feedback and the impact they offer, which means they'll vary from time to time.


About RNS Reach announcements

This is an RNS Reach announcement. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.


This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t